Molecular Data Inc. [NASDAQ: MKD] price surged by 4.19 percent to reach at $0.01. The company report on December 14, 2021 that MKD sets its eyes on supercomputing in North America.
Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that the Company has entered an agreement to form a Joint Venture to build supercomputing clusters in North America. The new Joint Venture plans to construct two plants in the USA and start operating on one plant in the next two months in the initial phase. The Company expects to add 13MW in the initial phase. The new business line is expected to generate approximately US$5 million in revenue and US$4 million in gross profit.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
The Company has made a strategic decision to develop blockchain technologies to add on to its chemical platform infrastructure given the rising needs for Digital factories and Smart manufacturing. This is a critical migration into Industrial Metaverse from Industrial Internet. Industrial Metaverse can solve the pain points of enterprises and aid in their digital transformation.”.
A sum of 6740916 shares traded at recent session while its average daily volume was at 9.05M shares. Molecular Data Inc. shares reached a high of $0.225 and dropped to a low of $0.2011 until finishing in the latest session at $0.22.
Guru’s Opinion on Molecular Data Inc. [MKD]:
The Average True Range (ATR) for Molecular Data Inc. is set at 0.02, with the Price to Sales ratio for MKD stock in the period of the last 12 months amounting to 0.04.
MKD Stock Performance Analysis:
Molecular Data Inc. [MKD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.87. With this latest performance, MKD shares dropped by -18.64% in over the last four-week period, additionally sinking by -75.06% over the last 6 months – not to mention a drop of -73.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MKD stock in for the last two-week period is set at 42.21, with the RSI for the last a single of trading hit 44.64, and the three-weeks RSI is set at 41.04 for Molecular Data Inc. [MKD]. The present Moving Average for the last 50 days of trading for this stock 0.2716, while it was recorded at 0.2190 for the last single week of trading, and 0.5766 for the last 200 days.
Insight into Molecular Data Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Molecular Data Inc. [MKD] shares currently have an operating margin of -4.36 and a Gross Margin at -0.13. Molecular Data Inc.’s Net Margin is presently recorded at -4.32.
Additionally, MKD Total Debt to Total Capital is recorded at 137.48, with Total Debt to Total Assets ending up at 14.96.
Reflecting on the efficiency of the workforce at the company, Molecular Data Inc. [MKD] managed to generate an average of -$251,431 per employee. Receivables Turnover for the company is 49.59 with a Total Asset Turnover recorded at a value of 12.55.Molecular Data Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.90 and a Current Ratio set at 0.90.
Molecular Data Inc. [MKD] Insider Position Details
There are presently around $1 million, or 5.50% of MKD stock, in the hands of institutional investors. The top three institutional holders of MKD stocks are: TB ALTERNATIVE ASSETS LTD. with ownership of 5,000,000, which is approximately 0% of the company’s market cap and around 10.08% of the total institutional ownership; HUDSON BAY CAPITAL MANAGEMENT LP, holding 1,486,842 shares of the stock with an approximate value of $0.33 million in MKD stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $6000.0 in MKD stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Molecular Data Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 6 institutional holders increased their position in Molecular Data Inc. [NASDAQ:MKD] by around 1,562,936 shares. Additionally, 4 investors decreased positions by around 370,548 shares, while 3 investors held positions by with 4,680,634 shares. The mentioned changes placed institutional holdings at 6,614,118 shares, according to the latest SEC report filing. MKD stock had 5 new institutional investments in for a total of 1,559,949 shares, while 4 institutional investors sold positions of 370,548 shares during the same period.